The drug Voglibite-GM 1/0.3 Tablet SR is categorised as an anti-diabetic medication. Adults with type 2 diabetes mellitus are treated with a mix of medicines. Diabetes sufferers benefit from improved blood sugar management.

Usage instructions-

• Use as directed by your doctor.

How It Works-

Glimepiride, metformin, and voglibose are the three anti-diabetic drugs included in Voglibite-GM 1/0.3 Tablet SR. When one therapy or a combination of therapies is ineffective, they function through several ways to offer improved blood sugar management. Glimepiride, a sulfonylurea, reduces blood sugar by boosting the amount of insulin the pancreas secretes. The biguanide metformin decreases glucose synthesis in the liver, slows glucose absorption from the intestines, and improves insulin sensitivity in the body. Voglibose, an alpha-glucosidase inhibitor, prevents the conversion of complex carbohydrates into simple sugars like glucose.

Safety information-

Pregnancy

Voglibite-GM 1/0.3 Tablet SR is maybe not safe to use in pregnancy. There are limited human studies, but animal studies have shown adverse effects on the developing baby. Talk to your doctor.

Breastfeeding

It is not safe to breastfeed while taking Voglibite-GM 1/0.3 Tablet SR. There is limited human data suggesting that the drug may enter breast milk and cause harm to the baby.

Alcohol

It is unsafe to take Alcohol with Voglibite-GM 1/0.3 Tablet SR.

Driving

If you have too high or too low blood sugar, it could affect your ability to drive. If you experience these symptoms, don't drive.

Kidney

Voglibite-GM 1/0.3 Tablet SR is most likely unsafe for use in people with kidney disease. Please consult to your physician.

Liver 

Voglibite-GM 1/0.3 Tablet SR should be taken with caution in people with liver problems. Voglibite-GM 1/0.3 Tablet SR dosage adjustments may be required. Please consult your doctor.